Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Efficacy of ACE inhibitors in chronic heart failure with preserved ejection fraction--a meta analysis of 7 prospective clinical studies.

Fu M, Zhou J, Sun A, Zhang S, Zhang C, Zou Y, Fu M, Ge J.

Int J Cardiol. 2012 Feb 23;155(1):33-8. doi: 10.1016/j.ijcard.2011.01.081. Epub 2011 Apr 11.

PMID:
21481482
2.

Meta-analysis of Renin-Angiotensin-aldosterone blockade for heart failure in presence of preserved left ventricular function.

Meune C, Wahbi K, Duboc D, Weber S.

J Cardiovasc Pharmacol Ther. 2011 Sep-Dec;16(3-4):368-75. doi: 10.1177/1074248410391667. Epub 2010 Dec 30. Review.

PMID:
21193681
3.

[Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].

Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.

Ital Heart J. 2005 Nov;6 Suppl 7:14S-23S. Review. Italian.

PMID:
16485513
4.
5.

Congestive heart failure: what should be the initial therapy and why?

Chatterjee K.

Am J Cardiovasc Drugs. 2002;2(1):1-6. Review.

PMID:
14727993
6.

ACE inhibitors in heart failure: what more do we need to know?

Demers C, Mody A, Teo KK, McKelvie RS.

Am J Cardiovasc Drugs. 2005;5(6):351-9. Review.

PMID:
16259523
7.

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.

Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.

Eur Heart J. 2005 Oct;26(20):2154-8. Epub 2005 Jul 13. Review.

PMID:
16014644
8.

Experience with beta blockers in heart failure mortality trials.

Eichhorn EJ.

Clin Cardiol. 1999 Oct;22 Suppl 5:V21-9. Review.

9.

Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure.

Kazi D, Deswal A.

Cardiol Clin. 2008 Feb;26(1):1-14, v. doi: 10.1016/j.ccl.2007.12.001. Review.

PMID:
18312901
12.

Pharmacotherapy of heart failure with normal ejection fraction (HFNEF)--a systematic review.

Rajagopalan S, Arora A, Shafiq N, Reddy S S, Pandhi P, Mittal N, Malhotra S.

Br J Clin Pharmacol. 2011 Sep;72(3):369-80. doi: 10.1111/j.1365-2125.2011.03998.x. Review.

13.

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Meta-analysis Global Group in Chronic Heart Failure (MAGGIC).

Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6. Review.

PMID:
21821849
14.

Outcomes in patients with heart failure with preserved ejection fraction.

Poppe KK, Doughty RN.

Heart Fail Clin. 2014 Jul;10(3):503-10. doi: 10.1016/j.hfc.2014.04.012. Review.

PMID:
24975912
15.

[Heart failure with preserved ejection fraction].

Špinar J, Vítovec J, Špinarová L.

Vnitr Lek. Fall 2016;62(7-8):646-51. Review. Czech.

PMID:
27627092
16.

Clinical trials in patients with heart failure and preserved left ventricular ejection fraction.

Cleland JG, Pellicori P, Dierckx R.

Heart Fail Clin. 2014 Jul;10(3):511-23. doi: 10.1016/j.hfc.2014.04.011. Review.

PMID:
24975913
17.

[Does treatment improve prognosis of heart failure with preserved ejection fraction?].

Schläpfer-Pessina A, Carballo S, Perrier A, Garin N.

Rev Med Suisse. 2015 Jan 21;11(458):199-205. Review. French.

PMID:
25831613
18.

Thirty Years of Evidence on the Efficacy of Drug Treatments for Chronic Heart Failure With Reduced Ejection Fraction: A Network Meta-Analysis.

Burnett H, Earley A, Voors AA, Senni M, McMurray JJ, Deschaseaux C, Cope S.

Circ Heart Fail. 2017 Jan;10(1). pii: e003529. doi: 10.1161/CIRCHEARTFAILURE.116.003529. Review.

19.

ACE inhibitors and ARBs in chronic heart failure: the established, the expected, and the pragmatic.

Poole-Wilson PA.

Med Clin North Am. 2003 Mar;87(2):373-89. Review.

PMID:
12693730
20.

The treatment of heart failure with preserved ejection fraction ("diastolic heart failure").

Hogg K, McMurray J.

Heart Fail Rev. 2006 Jun;11(2):141-6. Review.

PMID:
16937033

Supplemental Content

Support Center